Penn Ties update November 2016 FTF.

Slides:



Advertisements
Similar presentations
Yasir Rudha, MD; Amr Aref, MD; Paul Chuba, MD; Kevin O’Brien, MD
Advertisements

PET/CT in Oncology George Segall, M.D. Stanford University.
Ulrik Lassen MD, PH.D Phase 1 Unit
Cancer Registry Coding Changes for 2014 Presented by the Kentucky Cancer Registry February, 2014.
Michael Birrer, PI, Director, Gynecologic Medical Oncology, MGH Lari Wenzel, Co-PI, Prof. of Medicine, University of California, Irvine
Understand our institutional environments, needs and goals Review the contents of the Network Agreement and identify barriers to completion Agree on and/or.
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
Cancer Staging. What is cancer staging? Staging describes the severity of a person’s cancer based on the extent of the original (primary) tumor and whether.
TRAM Educational Conference September 19, 2014 Meritus Medical Center 1.
Ken Quinn Research Applications Administrator Information Technology Roswell Park Cancer Institute Christine O’Connell Sr. Director Laboratory Research.
Procedures used by CHTN
1 Research Data Marts In Support Of Cancer Personalized Medicine Jack London, PhD and Devjani Chatterjee, PhD Jefferson Kimmel Cancer Center, Philadelphia.
Joint Hospital Surgical Grand Round 21 st July, 2012 RH.
2nd Quebec Conference on Therapeutic Resistance in Cancer Bienvenue !!!!!
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
Epidemiological study on INVASIVE BREAST CANCER treated at Hotel Dieu de France Hospital University of Saint-Joseph Faculty of Medicine Gerard Abadjian,
Introduction to Pathology
Putting the Puzzle Together: Breast Collaborative Staging Melissa Riddle, RHIT, CTR October 6, 2012.
Dan Spratt, MD Department of Radiation Oncology Neuroendocrine Prostate Cancer: FDG-PET and Targeted Molecular Imaging.
PrognoChip Mediator, FORTH-ICS 1 Integrating Clinical and Genomic Information through the PrognoChip Mediator Implemented by Manos Kalaitzakis, Dimitris.
1 Jack London, PhD Research Professor, Cancer Biology Thomas Jefferson University Informatics Shared Resource Director Sidney Kimmel Cancer Center at Jefferson.
CASEFINDING Debra W. Christie, MBA, RHIA, CTR, CCRP Director, Cancer Research & Data Center University of Mississippi Medical Center.
Integrated Data Management System for the Biorepository.
New Oslo PSC biobank.  Broad consent – covers all clinical and research biobanking  Integrated storage of clinical data and biological material  DNA,
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport Gábor Lakatos 09 november th Conference of the Hungarian & 2 nd Conference.
October 9 th, 2015 University of Pennsylvania TIES Cancer Research Network Y3 Face to Face Meeting U24 CA Session 1 Project Status Updates.
Understanding Cancer and Related Topics
October 9 th, 2015 University of Pennsylvania TIES Cancer Research Network Y3 Face to Face Meeting U24 CA Session 6 User Stories and Pilot Studies.
Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.
Should liver metastases of breast cancer be biopsied to improve treatment choice? M. A. Locatelli, G. Curigliano, L. Fumagalli, V. Bagnardi, G. Aurilio,
Lecture # 42 NEOPLASIA - 3 Dr
W. Scott Campbell, Ph.D., MBA University of Nebraska Medical Center
INTERPRETING GENETIC MUTATIONAL DATA FOR CLINICAL ONCOLOGY Ben Ho Park, M.D., Ph.D. Associate Professor of Oncology Johns Hopkins University May 2014.
Facilitating tissue collection for translational research Jane Rogan Business Manager.
Bladder Cancer Mark Browning, M.D. ‘ IUSME.
NPCR Data Completeness and Quality Audits Review of: Collaborative Stage and Surgery Data Mary Lewis, CTR NPCR Program Consultant.
R2 김재민 / Prof. 정재헌 Journal conference 1.
The Bridge from Patient to Scientist Comparison: BioBank and Cancer Registry Data Source Distinct Patients Percent BioBank % Cancer Registry %
WEB-BASED APPLICATION for DIGITAL PATHOLOGY and MOLECULAR ANALYSIS Dave Billiter, BA, PMP, Tom Barr, BS, Mark Plaskow, BA, MCSD, Kathy Nicol, MD Research.
Increasing demand for FFPE for molecular characterization Genomic tumor profiling of retrospective cases growing Recent studies show tumor DNA extracted.
A Data Revolution is Coming - Revitalizing our AP data through Natural Language Processing and Federated Data Sharing Rebecca Crowley Jacobson, MD, MS.
An introduction to Breast Cancer and Unmet Clinical Needs
TCRN F2F Meeting 2016.
5 Different Observational Datasets: Pros & Cons
Cancer Genomics and Class Discovery
 [P1]Can you put in the numbers here for specificity and NPV
Cancer unchecked growth that progresses toward limitless expansion.
CUP SSG May 2016 Dr Matt sephton
Figure 1. MORT gene silencing is early event in cancer
Somerset Cancer Register
معيارهاي ارزشيابي برنامه ثبت سرطان دانشگاهي ارسال به موقع اطلاعات (هر سه ماه)(2) گردآوري از لحاظ پيدا كردن موارد جديد سرطاني از منابع ذيل: - ثبت.
Metastatic Breast cancer
سرطان الثدي Breast Cancer
What’s New for 8th Edition
Dr T P E Wells 13 July 2018 Breast SSG Bath
Development of preclinical models for the guidance of precision medicine. Development of preclinical models for the guidance of precision medicine. A,
Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center  Anthony N. Sireci, Vimla S. Aggarwal, Andrew T.
Loyola Marymount University
Handling and Evaluation of Breast Cancer Biopsy
Loyola Marymount University
Tracing the Innate Genetic Evolution and Spatial Heterogeneity in Treatment Naïve Lung Cancer Lesions Jihye Kim Translational Bioinformatics and Cancer.
Loyola Marymount University
Loyola Marymount University
Loyola Marymount University
・FFPE tumor tissue array (Biochain, cat. T )
Dr Lesley Anderson PhD MPHe BSc(Hons) PGCHET FHEA
Fig. 9. A 56-year-old woman, who underwent chemotherapy due to advanced gastric cancer, complained of swelling and erythema of left breast. She underwent.
Strategies for personalized precision immunotherapy.
Dan Geschwind, MD, PhD Director, Institute for Precision Health
Presentation transcript:

Penn Ties update November 2016 FTF

Penn Team Michael Feldman, Assoc Prof Path & Lab Med – Site PI Joellen Weaver – Director SOM Biobank – Regulatory and Admin Nate Digiorgio – Sys Admin and DBA – Kevin Lux – Interface Tara McSherry – End user training and support, QA Fred Valdivieso – Tissue bank manager – honest broker

Database Latest code set running 5.6 Records coded ~940K Active coding pipeline via daily data load from Medview (home grown web portal for lab results) Catching all Surg path cases from 3 hospitals downtown hospitals at Penn Medicine (65K/yr)

Roll out Roll Out SOM Biobank as honest broker 35 Active users on the system Expanding to more cancer center investigators Monthly training Working with new Cancer Center CIO SOM Biobank as honest broker

Value TIES study in prep to research Query – Find all pancreas cancer cases where we have the primary tumor along with metastatic tumor Results – 41 cases of primary and mets Exomes, RNAseq and Immune Neoantigen scores 500K Supplement to our Cancer Center P30 grant to study these pairs to look for drivers in metastatic progression

Value TIES study in prep to research Query – Find all triple negative breast cancer cases where we have the primary tumor along with metastatic tumor Results – 73 cases of primary and mets Pulling cases to start new Basser Center Study Exomes, RNAseq and Immune Neoantigen scores Other Cancer specific groups are interested GI – Colon, esophagus

Value Clinical Assay Development Retrospective cohort study Find cases in neuropathology that look infectious but for which no organism has been found Test set to look at new tools to discover infectious agents DNA and RNA seq to look for agents Pathochip to look for agents

Research study Rosai Dorfman Disease Rosai Dorfman disease is an idiopathic reactive condition characterized by exuberant macrophage reaction in lymph nodes or soft tissue Etiology is unknown but some studies have implicated a virus, Herpes virus 6 in some cases Pathochip is a microarray technology All known pathogenic virus and bacteria and fungi arrayed Allows FFPE to be probed for infectious signature in lesional tissue compared to normal controls

“Breast Papilloma study” Find all breast needle cores with diagnosis of a papilloma but nothing worse at the time of or before the core biopsy who then went on to a subsequent resection In the resection after the papilloma core biopsy, what is the frequency of finding either in situ or invasive carcinoma Compare the carcinoma rate to carcinoma in a random core biopsy population with BIRADS4

Structured + NLP How can we link structured data with TIES? Pathology Biobank – LIMS is labvantage, same at RPCI Oncology – tumor registry Metriq similar to Pitt and RPCI

Virtual slides at Penn Need to get our vslides coded for use in TIES We have ~40K slides in spectrum, some subset is usable with TIES

How can TIES be expanded (more corpuses) Radiology Oncology Diagnosis Response Criteria (RECIST) – Lesion changes, Lymph node size, bone lesion, PET… Heterogeneity – structural (CT and MRI) and genomic (PET) Integrated process research – precision medicine